Back

Metabolic burden matters: hypertension and diabetes amplify the predictive power of cardiometabolic indices for coronary artery disease — a 10-year prospective cohort study

30 August 2026 (12:15 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic burden Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Leila Bikdelu

Mashhad University of Medical Sciences, Mashhad (Iran (Islamic Republic of))

4 More presentations in this session

Presentation thumbnail
Systemic inflammation biomarkers as independent predictors of mortality in critically Ill cardiac patients
Doctor A. Qadan (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Cardiovascular risk factor burden in preserved ratio impaired spirometry (PRISm): a meta-analysis.
Doctor E. Pirera (Palermo, IT)
Abstract Slides
Presentation thumbnail
Opportunistic CT-based assessment of pectoralis major sarcopenia and risk of incident atrial fibrillation
Doctor G. Cobb (La Jolla, US)
Abstract Slides
Presentation thumbnail
Association between cardiometabolic index and the incidence of cardiovascular disease in hypertensive patients
Associate Professor L. Bikdelu (Mashhad, IR)

Access the full session

Session thumbnail
Cardiometabolic burden

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Usefulness of cardiometabolic index for the estimation of diabetes risk among general population in rural China: a community-based study
17 April 2021
thumbnail
Congress Presentation
Comparison of the predictive role of changes in left ventricular mass and arterial stiffness for coronary artery disease in essential hypertension: Data from a 8-year-follow-up study
3 September 2019
thumbnail
Congress Presentation
Metabolic syndrome and mortality prediction in the seven countries' study: single or multifactorial
28 August 2020
thumbnail
Congress Presentation
Incident CHD, residual risk and traditional cardiovascular risk factors in the community: role of lipid-inflammatory axis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources